1. Home
  2. Products
  3. MUC16

MUC16

MUC16, also known as CA-125 (cancer agent 125 or carcinoma antigen 125), is a cell surface protein that is actively expressed in corneal and conjunctival epithelia. It is a heavily N-glycosylated large membrane-associated mucin protein with over 22000 amino acids and structurally, it is divided into a Ser/Thr-rich N-terminal domain, a C-terminal transmembrane contain domain, and a highly repetitive middle domain that is comprised of more than 60 partially conserved tandem repeats. The hydrophilicity of MUC16 created by its glycans enables MUC16 to provide a lubricating barrier against infectious agents and particles while its cytoplasmic tail has also been indicated to bind members of the ERM protein family and interact with cytoskeleton.

The overexpression of MUC16 has been associated with several carcinomas, especially ovarian carcinomas and ovarian low malignant potential (LMP) tumors. MUC16 has served as a biomarker for ovarian carcinoma for a long time and it is believed to facilitate cancer development by mechanisms including immune system evasion, metastatic invasion, induced motility, and chemotherapy resistance. Thus, it is an important therapeutic target for ovarian cancer.

Entrez Gene ID: 94025
UniProt ID: Q8WXI7

Catalog Product name Similar to Antibody Linker Payload Data sheet Inquiry
ADC-W-020 Anti-MUC16 (clone 3A5)-Mc-VC-PABC-MMAE ADC Chimeric Anti-MUC16 antibody, clone # std ch 3A5 MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE (Monomethyl auristatin E) Inquiry
ADC-W-022 Anti-MUC16 (clone 3A5)-VC-MMAE ADC Anti-MUC16-antibody, clone # std ch 3A5 VC (valine-citrulline) MMAE (Monomethyl auristatin E) Inquiry
ADC-W-154 Anti-MUC16 (clone 3A5)-BMPEO-DM1 ADC Anti-MUC16 antibody, clone # 3A5 BMPEO (bis-maleimido-trioxyethylene glycol) DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) Inquiry
ADC-W-238 Anti-MUC16 (clone ch11D10)-Mc-MMAF ADC Chimeric Anti-MUC16 lgG1 Antibody, clone # ch11D10 Mc (maleimidocaproyl) MMAF (Monomethyl auristatin F) Inquiry
ADC-W-239 Anti-MUC16 (clone ch11D10)-VC-MMAF ADC Chimeric Anti-MUC16 lgG1 Antibody, clone # ch11D10 VC (valine-citrulline) MMAF (Monomethyl auristatin F) Inquiry
ADC-W-427 Anti-MUC16 (Sofituzumab)-VC-MMAE ADC Humanized Anti-MUC16 Antibody, Sofituzumab VC (valine-citrulline) MMAE (Monomethyl auristatin E) Inquiry
ADC-W-466 Anti-MUC16-Mc-VC-PABC-MMAE ADC Chimeric Anti-MUC16 Antibody MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE (Monomethyl auristatin E) Inquiry
ADC-W-564   Anti-MUC16-VC-MMAE ADC RG-7458 Anti-MUC16 Antibody VC (valine-citrulline) MMAE (Monomethyl auristatin E) Inquiry
ADC-W-1634 Anti-MUC16 (Abagovomab)-SMCC-DM1 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) Inquiry
ADC-W-1635 Anti-MUC16 (Abagovomab)-SPDB-DM4 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) Inquiry
ADC-W-1636 Anti-MUC16 (Abagovomab)-MC-MMAF ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab MC (maleimidocaproyl) MMAF Inquiry
ADC-W-1637 Anti-MUC16 (Abagovomab)-MC-Vc-PAB-MMAE ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE Inquiry
ADC-W-1638 Anti-MUC16 (Abagovomab)-MC-Vc-PAB-SN38 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin) Inquiry
ADC-W-1639 Anti-MUC16 (Abagovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA Inquiry
ADC-W-1640 Anti-MUC16 (Igovomab)-SMCC-DM1 ADC Murine Anti-MUC16 Fab2 fragment, Igovomab SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) Inquiry
ADC-W-1641 Anti-MUC16 (Igovomab)-SPDB-DM4 ADC Murine Anti-MUC16 Fab2 fragment, Igovomab SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) Inquiry
ADC-W-1642 Anti-MUC16 (Igovomab)-MC-MMAF ADC Murine Anti-MUC16 Fab2 fragment, Igovomab MC (maleimidocaproyl) MMAF Inquiry
ADC-W-1643 Anti-MUC16 (Igovomab)-MC-Vc-PAB-MMAE ADC Murine Anti-MUC16 Fab2 fragment, Igovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE Inquiry
ADC-W-1644 Anti-MUC16 (Igovomab)-MC-Vc-PAB-SN38 ADC Murine Anti-MUC16 Fab2 fragment, Igovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin) Inquiry
ADC-W-1645 Anti-MUC16 (Igovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Murine Anti-MUC16 Fab2 fragment, Igovomab MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA Inquiry
ADC-W-1646 Anti-MUC16 (Oregovomab)-SMCC-DM1 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) Inquiry
ADC-W-1647 Anti-MUC16 (Oregovomab)-SPDB-DM4 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) Inquiry
ADC-W-1648 Anti-MUC16 (Oregovomab)-MC-MMAF ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab MC (maleimidocaproyl) MMAF Inquiry
ADC-W-1649 Anti-MUC16 (Oregovomab)-MC-Vc-PAB-MMAE ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE Inquiry
ADC-W-1650 Anti-MUC16 (Oregovomab)-MC-Vc-PAB-SN38 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin) Inquiry
ADC-W-1651 Anti-MUC16 (Oregovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA Inquiry
ADC-W-2565 Anti-MUC16 (Sofituzumab)-SMCC-DM1 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) Inquiry
ADC-W-2566 Anti-MUC16 (Sofituzumab)-SPDB-DM4 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) Inquiry
ADC-W-2567 Anti-MUC16 (Sofituzumab)-MC-MMAF ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab MC (maleimidocaproyl) MMAF Inquiry
ADC-W-2568 Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-MMAE ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE Inquiry
ADC-W-2569 Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-SN38 ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin) Inquiry
ADC-W-2570 Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA Inquiry

If you can’t find your product on this list? Please directly send email to info@creative-biolabs.com

For Research Use Only. NOT FOR CLINICAL USE.

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.